HCC Biomarkers Current and Future Use
HBV 5 Line Guideline (Proposed):
- Test all adults for Hepatitis B with the triple panel: HBsAg, AntiHBc total, AntiHBs
- Vaccinate all adults for HBV who are HBV triple panel negative
- If HB surface antigen positive, link to HBV DNA quant and Hep delta total antibody
- Treat all individuals who are HBV DNA positive
- Stage liver disease and start surveillance for liver cancer and other forms of Liver Disease
Видео HCC Biomarkers Current and Future Use канала Robert Gish
- Test all adults for Hepatitis B with the triple panel: HBsAg, AntiHBc total, AntiHBs
- Vaccinate all adults for HBV who are HBV triple panel negative
- If HB surface antigen positive, link to HBV DNA quant and Hep delta total antibody
- Treat all individuals who are HBV DNA positive
- Stage liver disease and start surveillance for liver cancer and other forms of Liver Disease
Видео HCC Biomarkers Current and Future Use канала Robert Gish
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
![Drug, Supplement and Herbal Induced Liver Disease](https://i.ytimg.com/vi/mJjXtPVh-N8/default.jpg)
![identifying and managing hepatitis b covid19](https://i.ytimg.com/vi/5Yikay7PkXQ/default.jpg)
![When to Transfer Liver Patients to the ICU and to a LT center](https://i.ytimg.com/vi/qi0coo-_T6k/default.jpg)
![National Hepatitis Testing Day 2014 PSA - Robert Gish, MD](https://i.ytimg.com/vi/tM1W32hVi94/default.jpg)
![NASH and Cardiovascular Lecture](https://i.ytimg.com/vi/hnAEN48GxHo/default.jpg)
![From the Floor to the ICU to You](https://i.ytimg.com/vi/AHLdex09sq4/default.jpg)
![Jamie's Story #BtheVoice #B肝之聲](https://i.ytimg.com/vi/78ukkxss7s4/default.jpg)
![Evaluation of a Patient for Cirrrhosis and Subsequent Medical Management](https://i.ytimg.com/vi/zwTYpzGoyrk/default.jpg)
![Care of the LIVER Patient in the Hospital - When to Transfer](https://i.ytimg.com/vi/xGC_7Ulao5Y/default.jpg)
![Drug, Supplement and Herbal Induced Liver Disease](https://i.ytimg.com/vi/6Sis41By3XQ/default.jpg)
![Hepatitis B: Update 2021 Webinar](https://i.ytimg.com/vi/5qnU00rntEo/default.jpg)
![When to Transfer Liver Patients to the ICU and to a LT Center](https://i.ytimg.com/vi/Del0zaqFQoQ/default.jpg)
![Current Data and Expert Insights - Hepatocellular Cancer by Robert Gish, MD](https://i.ytimg.com/vi/INKT0x2v_Qs/default.jpg)
![Covid-19: All-Star Panel on Current Issues](https://i.ytimg.com/vi/w_pdjTtHdzc/default.jpg)
![NASH ASH vs. MAFLD](https://i.ytimg.com/vi/bJzMUOWsk8g/default.jpg)
![MAFLD 2022](https://i.ytimg.com/vi/Bceb47JV-dg/default.jpg)
![NITS and NASH - What We Know in 2021](https://i.ytimg.com/vi/76K0NHBmuxs/default.jpg)
![Intro to Hepatology via APHF and Skaggs School of Pharmacy](https://i.ytimg.com/vi/7y_6ey4WbWc/default.jpg)
![NASH ASH vs. MAFLD: Diagnostic and Treatment Implications](https://i.ytimg.com/vi/yGJh1tP1EVM/default.jpg)
![Screening for Liver Disease - 2023](https://i.ytimg.com/vi/lQp8Ph7uEOQ/default.jpg)